Bhagalpur, India

Manoj Kumar

This inventor holds 1 USPTO granted patent. Top assignee: Innoplexus Ag. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Manoj Kumar. Retrieved from https://idiyas.com/inventor/manoj-kumar-t3ju1zqu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Manoj Kumar in Cancer Treatment

Introduction

Manoj Kumar is a notable inventor based in Bhagalpur, India. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on the treatment of pancreatic cancer, a disease that poses significant challenges in the medical community.

Latest Patents

Manoj Kumar holds a patent for "Phosphoinositide 3-kinase and Src inhibitors for treatment of pancreatic cancer." This patent describes a phosphoinositide 3-kinase inhibitor that is used in the treatment of pancreatic cancer. The method includes the administration of both a phosphoinositide 3-kinase inhibitor and an Src inhibitor to a human subject in need of treatment. Additionally, the patent provides a pharmaceutical composition that comprises both inhibitors, showcasing a novel approach to combat this aggressive form of cancer.

Career Highlights

Manoj Kumar is currently associated with Innoplexus AG, where he continues to advance his research in cancer therapies. His dedication to innovation in the pharmaceutical field has positioned him as a key figure in the development of effective treatments for pancreatic cancer.

Collaborations

Manoj collaborates with talented professionals such as Amit Choudhari and Deepak Sharma. Their combined expertise enhances the research and development efforts at Innoplexus AG, fostering an environment of innovation and discovery.

Conclusion

Manoj Kumar's contributions to cancer treatment through his patent on phosphoinositide 3-kinase and Src inhibitors highlight his commitment to improving patient outcomes. His work exemplifies the impact of innovative research in the medical field, particularly in the fight against pancreatic cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…